Cargando…
Fibroblast Growth Factor 21 Protects against Atherosclerosis via Fine-Tuning the Multiorgan Crosstalk
Fibroblast growth factor 21 (FGF21) is a metabolic hormone with pleiotropic effects on energy metabolism and insulin sensitivity. Besides its antiobese and antidiabetic activity, FGF21 also possesses the protective effects against atherosclerosis. Circulating levels of FGF21 are elevated in patients...
Autores principales: | Jin, Leigang, Lin, Zhuofeng, Xu, Aimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Diabetes Association
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768047/ https://www.ncbi.nlm.nih.gov/pubmed/26912152 http://dx.doi.org/10.4093/dmj.2016.40.1.22 |
Ejemplares similares
-
Fibroblast Growth Factor 21 Prevents Atherosclerosis by Suppression of Hepatic Sterol Regulatory Element-Binding Protein-2 and Induction of Adiponectin in Mice
por: Lin, Zhuofeng, et al.
Publicado: (2015) -
Therapeutic effects of fibroblast growth factor-21 against atherosclerosis via the NF-κB pathway
por: Zhang, Yiming, et al.
Publicado: (2018) -
Fibroblast Growth Factor 21 Mimetics for Treating Atherosclerosis
por: Kwok, Kelvin H. M., et al.
Publicado: (2017) -
Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes
por: Xiao, Yang, et al.
Publicado: (2015) -
Fibroblast Growth Factor 21 Protects Against Atrial Remodeling via Reducing Oxidative Stress
por: Chen, Miao, et al.
Publicado: (2021)